EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diversion of Diacetylmorphine in Heroin-Assisted Treatment: A Focus Group Study among Patients and Treatment Providers

Elisabeth Strickler, Zacharias Wicki, Jean N Westenberg, Johannes Strasser, Undine E Lang, Kenneth M Dürsteler, Maximilian Meyer, Marc Vogel

European Addiction Research · 2025

DOI: 10.1159/000545162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Addiction Research, 2025. Verfasst von Elisabeth Strickler und 7 weiteren Autor:innen. Beteiligte Einrichtung: University Psychiatric Clinics Basel, University of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Heroin, Analgesics, Opioid, Opioid-Related Disorders, Prescription Drug Diversion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Heroin-assisted treatment (HAT) involves the supervised administration of pharmaceutical heroin (diacetylmorphine; DAM), either injectable or oral, for individuals with severe opioid use disorder who have not achieved stabilisation with conventional opioid agonist treatment. Despite its growing adoption, there is limited literature on the phenomenon of diversion in HAT. Diversion refers to the redirecting of legal prescription medications from their intended medical use to illegal or unauthorised use. This study aimed to investigate the reasons for, experiences with, and consequences of DAM diversion, as reported by both patients and treatment providers.

Methods

In this qualitative study, two separate focus groups were conducted with patients and treatment providers (nurses, psychiatrists, social workers, and psychologists), respectively. Discussions were audio-recorded, transcribed, and analysed. Mayring’s qualitative content analysis was used to evaluate the findings.

Results

Five themes with fourteen categories emerged. Providers and patients both described procedures and motives of diversion, discussed the positive and negative consequences, and suggested solutions for reduced future diversion of DAM. An important motif for diversion stemmed from patients’ urge for more autonomy over route, timing, and fractioning of administration, while also being used to finance concurrent cocaine use. Treatment providers and patients both noted that diversion may lead to increased overdose risk for individuals in and out of treatment. Nurses noted a substantial negative impact of diversion on the therapeutic relationship. Suggestions for reducing diversion included allowing for more take-home dosing, allowing for more flexibility in routes of administration, adapting HAT clinic opening hours, and providing effective treatment for cocaine use disorder.

Conclusion

The main drivers of diversion in HAT included a desire for more autonomy, unaddressed concurrent substance use, and significant barriers to the existing treatment options. Addressing patients’ preferred opioid effect profile, accommodating their social needs, and managing concurrent cocaine use disorders may reduce diversion in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeroinAnalgesics, OpioidOpioid-Related DisordersPrescription Drug DiversionDrug UsersHealth PersonnelOpiate Substitution TreatmentQualitative ResearchFocus GroupsNursesPsychiatristsSocial WorkersPsychologistsMotivationPersonal AutonomyHumansMaleFemaleAdultMiddle Aged

Stichwörter der Autor:innen

DiversionOpioid agonist treatmentOpioid use disorderQualitative researchSmuggling

Substanzen

HeroinAnalgesics, Opioid

Autor:innen und Institutionen

  • University Psychiatric Clinics Basel, University of Basel, Basel, Switzerland.
  • Faculty of Medicine, University of Basel, Basel, Switzerland.
  • School of Medicine, University College Cork, Cork, Ireland.
  • University Psychiatric Clinics Basel, University of Basel, Basel, Switzerland, maximilian.meyer@upk.ch.

Zitieren

APA

Strickler, E., Wicki, Z., Westenberg, J. N., Strasser, J., Lang, U. E., Dürsteler, K. M., Meyer, M., & Vogel, M. (2025). Diversion of Diacetylmorphine in Heroin-Assisted Treatment: A Focus Group Study among Patients and Treatment Providers. European Addiction Research. https://doi.org/10.1159/000545162

Vancouver

Strickler E, Wicki Z, Westenberg JN, Strasser J, Lang UE, Dürsteler KM, et al. Diversion of Diacetylmorphine in Heroin-Assisted Treatment: A Focus Group Study among Patients and Treatment Providers. European Addiction Research. 2025. doi:10.1159/000545162

BibTeX
@article{Strickler2025,
  author = {Strickler, Elisabeth and Wicki, Zacharias and Westenberg, Jean N and Strasser, Johannes and Lang, Undine E and Dürsteler, Kenneth M and Meyer, Maximilian and Vogel, Marc},
  title = {Diversion of Diacetylmorphine in Heroin-Assisted Treatment: A Focus Group Study among Patients and Treatment Providers},
  journal = {European Addiction Research},
  year = {2025},
  doi = {10.1159/000545162}
}
Kostenlos starten →